The "clinical trial" is that segment of research in the drug development process that tests the product or device to determine such factors as safety, efficacy, and adverse reactions in a human population. The report focuses on the role of the clinical trial in: the research and development of drugs, biologics, new applications for old drugs and devices; and the major product pipelines for the top biotechnology and biopharmaceutical companies.

 

This report discusses the current and future trends in clinical trial research and how these new focuses are driven by epidemiological trends, by the desire for treatment of rare diseases, and by the threat of bioterrorism. This report addresses those factors that are driving up the costs of clinical trials and the impact of new technologies on the costs and processes of clinical trials. This report includes an overview of the clinical trial including phases of the clinical trial, U.S. government regulations, international regulations, costs of clinical trials, technologies, Contract Research Organizations (CROs), and other factors. This report provides trends and projected costs of clinical trials through 2007.

 

128 pages.